Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Channing J Der

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
Trends in Biochemical Sciences|May 16, 2020
Binge Drinking: Macropinocytosis Promotes Tumorigenic Growth of RAS-Mutant CancersG Aaron Hobbs, Channing J Der
Cancer Cell|February 21, 2012
The RAF inhibitor paradox revisitedAdrienne D Cox, Channing J Der
Nature Cancer|February 20, 2025
Drugging mutant KRAS by disrupting binding to effectors and GTPAdrienne D Cox, Channing J Der
Nature|May 24, 2013
Cancer: Drug for an 'undruggable' proteinNicole M Baker, Channing J Der
The New England Journal of Medicine|May 6, 2026
Advances in RAS Therapeutics for Pancreatic CancerChanning J Der, Jen Jen Yeh
Cancer Biology & Therapy|March 19, 2003
Ras family signaling: therapeutic targetingAdrienne D Cox, Channing J Der
Science (New York, N.Y.)|October 7, 2021
Filling in the GAPs in understanding RASAdrienne D Cox, Channing J Der
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Validation of Isoform- and Mutation-Specific RAS AntibodiesAndrew M Waters, Channing J Der
Cancer Treatment and Research|March 5, 2003
Ras signaling, deregulation of gene expression and oncogenesisAylin S Ulkü, Channing J Der
Cell|June 2, 2007
Stopping ras in its tracksChanning J Der, Terry Van Dyke
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Trends in Biochemical Sciences|May 16, 2020
Binge Drinking: Macropinocytosis Promotes Tumorigenic Growth of RAS-Mutant CancersG Aaron Hobbs, Channing J Der
Cancer Cell|February 21, 2012
The RAF inhibitor paradox revisitedAdrienne D Cox, Channing J Der
Nature Cancer|February 20, 2025
Drugging mutant KRAS by disrupting binding to effectors and GTPAdrienne D Cox, Channing J Der
Nature|May 24, 2013
Cancer: Drug for an 'undruggable' proteinNicole M Baker, Channing J Der
The New England Journal of Medicine|May 6, 2026
Advances in RAS Therapeutics for Pancreatic CancerChanning J Der, Jen Jen Yeh
Cancer Biology & Therapy|March 19, 2003
Ras family signaling: therapeutic targetingAdrienne D Cox, Channing J Der
Science (New York, N.Y.)|October 7, 2021
Filling in the GAPs in understanding RASAdrienne D Cox, Channing J Der
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Validation of Isoform- and Mutation-Specific RAS AntibodiesAndrew M Waters, Channing J Der
Cancer Treatment and Research|March 5, 2003
Ras signaling, deregulation of gene expression and oncogenesisAylin S Ulkü, Channing J Der
Cell|June 2, 2007
Stopping ras in its tracksChanning J Der, Terry Van Dyke
Pageof 24